从危险到风险优先级:一个用基于生理学的动力模型来预测药物诱导胆固醇的案例研究
Véronique M P de Bruijn1, Ivonne M C M Rietjens2
1Division of Toxicology, Wageningen University and Research, Wageningen, The Netherlands.
Archives of toxicology
|May 16, 2024
概括
一个新的基于生理的动力学 (PBK) 模型通过评估胆酸积累来预测药物诱导的胆固醇. 这种方法可以识别由于药物清除速度缓慢或胆盐出口 (BSEP) 功能减少等因素而面临更高风险的个体.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 胆固醇症涉及肝脏中的胆酸积累,但临床症状很少出现.
- 预测药物诱导的胆固醇因胆酸排放抑制而产生的胆固醇是具有挑战性的.
研究的目的:
- 开发一种新方法方法 (NAM) 来预测药物诱导的胆固醇病.
- 评估药物对肝胆酸排放和积累的影响.
主要方法:
- 利用基于生理的动力学 (PBK) 药物模型来预测肝脏药物度.
- 将药物对胆汁酸排放的影响纳入胆汁酸的PBK模型.
- 使用预测的胆汁酸积累量化胆固醇强度.
主要成果:
- 药物胆固醇酶发生率与止常数 (Ki) 以上的肝脏内药物度 (AUC) 相比,单独Ki的相关性更好.
- 确定的危险因素:药物清除速度较慢,胆酸池较大,胆盐出口 (BSEP) 丰度减少,剂量较高.
- 经过验证的药物分类 (常见,罕见,没有胆固醇) 与模型预测相对应.
结论:
- 基于生理学的动力学 (PBK) 建模为优先考虑胆固醇风险提供了原则证明.
- 这个NAM可以识别药物诱导胆固醇症的个体风险因素.
- 该模型有助于理解与载体抑制相关的胆固醇酶机制.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Pharmacokinetic Models: Comparison and Selection Criterion
69
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
69
Pharmacokinetic Models: Overview
665
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
665
Physiological Pharmacokinetic Models: Assumption with Protein Binding
41
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
41
Mechanistic Models: Overview of Compartment Models
83
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
83
Model Approaches for Pharmacokinetic Data: Physiological Models
42
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
42


